胺碘酮联合美托洛尔治疗心律失常患者的临床研究进展

Clinical research progress of treatment arrhythmia patients by Amiodarone combined with Metoprolol

心律失常属于常见的心内科疾病,其可以分为快速性心律失常、缓慢性心律失常,临床治疗没有长期有效的药物,药物使用过多,会出现毒副作用,影响患者的治疗效果和预后恢复,选择有效、安全的药物,是治疗心律失常的重点问题。胺碘酮是临床常用抗心律失常药物,美托洛尔属于典型的β受体阻滞剂,其在临床广泛应用。本文对胺碘酮、美托洛尔治疗心律失常机制和研究进展进行了阐述,旨在为指导临床用药提供理论依据。

Arrhythmia belongs to common heart disease,with its quickness arrhythmia,tardy arrhythmia,can be divided into clinical treatment no effective drug for a long time,drug use too much,can appear side effect,influence the treatment effect and prognosis of patients with recovery,select effective and safe drug,are key problems in the treatment of arrhythmia.Amiodarone is a commonly used anti-arrhythmia drug in clinic,while Metoprolol is a typicalβreceptor blocker,which is widely used in clinic.In this paper,the mechanism and research progress of amiodarone and metoprolol in the treatment of arrhythmia were reviewed,aiming to provide theoretical basis for guiding clinical medication.